Key result
Proteomic experiments have identified over 1100 platelet proteins, novel signaling pathways, and secreted proteins that may represent therapeutic targets and potential cancer biomarkers.
Design
Review
Authors
Loading...
Platelet proteomic targets should not yet change practice; leaves open validation as cancer biomarkers or therapies in prospective studies.
Key points are not available for this paper at this time.
Senzel et al. (2009) reported a review. Proteomic experiments have identified over 1100 platelet proteins, novel signaling pathways, and secreted proteins that may represent therapeutic targets and potential cancer biomarkers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: